Conterno Enrique A

Chief Executive Officer at FGEN; SVP&Pres, LillyDiab & LillyUSA at LLY

Sold, on record
$14.8M
Dollars the filings state
Form 4 sales
24
Latest Jul 7, 2023
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • FGENFIBROGEN INCChief Executive Officer
  • LLYELI LILLY & CoSVP&Pres, LillyDiab & LillyUSA

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale LLYPlan not stated
    May 31 2018

    Sold 25,000 shares at $85.00 ($2.1M)

    Conterno Enrique A, SVP&Pres, LillyDiab & LillyUSA

    Sold 16.7% of holdings ($12.7M position)124,534 shares leftFiling

  2. 2 Form 4 sale LLYPlan not stated
    Feb 15 +260 days

    Sold 25,000 shares at $121.00 ($3M)

    Conterno Enrique A, SVP&Pres, LillyDiab & LillyUSA

    Sold 15.8% of holdings ($19.1M position)132,962 shares leftFiling

  3. 3 Form 4 sale FGENPlan not stated
    Dec 8 +1392 days

    Sold 2,543 shares at $15.79 ($40k)

    Conterno Enrique A, Chief Executive Officer

    Sold 0.8% of holdings ($4.7M position)297,020 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale FGENPlan not stated
    Jan 6 +29 days

    Sold 1,538 shares at $19.95 ($31k)

    Conterno Enrique A, Chief Executive Officer

    Sold 0.5% of holdings ($5.9M position)295,483 shares leftFiling

  5. 5 Form 4 sale FGENPlan not stated
    Mar 10 +63 days

    Sold 56,261 shares at $20.62 ($1.2M)

    Conterno Enrique A, Chief Executive Officer

    Sold 12.8% of holdings ($9.1M position)384,868 shares leftFiling

  6. 6 Form 4 sale FGENNo plan
    Apr 10 +31 days

    Sold 1,869 shares at $19.52 ($36k)

    Conterno Enrique A, Chief Executive Officer

    No 10b5-1 planSold 0.5% of holdings ($7.5M position)382,999 shares left0.7x usual sizeFiling

  7. 7 Form 4 sale FGENUnusual
    Jun 7 +58 days

    Sold 8,897 shares at $17.04 ($152k)

    Conterno Enrique A, Chief Executive Officer

    No 10b5-1 planSold 2.3% of holdings ($6.6M position)376,602 shares left4x usual sizeFiling

  8. 8 Form 4 sale FGENNo plan
    Jul 7 +30 days

    Sold 1,880 shares at $2.80 ($5k)

    Conterno Enrique A, Chief Executive Officer

    No 10b5-1 planSold 0.5% of holdings ($1.1M position)374,722 shares left0.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (24)

Form 144 notices and Form 4 sales by Conterno Enrique A
Source
Jul 7, 2023FGENChief Executive OfficerForm 4 sale1,880$5k0.5%No planSEC
Jun 7, 2023FGENChief Executive OfficerForm 4 sale8,897$152k2.3%UnusualSEC
Apr 10, 2023FGENChief Executive OfficerForm 4 sale1,869$36k0.5%No planSEC
Mar 10, 2023FGENChief Executive OfficerForm 4 sale56,261$1.2M12.8%Plan not statedSEC
Jan 6, 2023FGENChief Executive OfficerForm 4 sale1,538$31k0.5%Plan not statedSEC
Dec 8, 2022FGENChief Executive OfficerForm 4 sale2,543$40k0.8%Plan not statedSEC
Feb 15, 2019LLYSVP&Pres, LillyDiab & LillyUSAForm 4 sale25,000$3M15.8%Plan not statedSEC
May 31, 2018LLYSVP&Pres, LillyDiab & LillyUSAForm 4 sale25,000$2.1M16.7%Plan not statedSEC
May 4, 2017LLYSVP&Pres, LillyDiab & LillyUSAForm 4 sale25,000$2.1M18.0%Plan not statedSEC
Dec 9, 2015LLYSr. VP & Pres., Lilly DiabetesForm 4 sale25,000$2.1M22.1%UnusualSEC
Nov 3, 2014LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$330k6.4%Plan not statedSEC
Oct 1, 2014LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$324k6.0%Plan not statedSEC
Sep 2, 2014LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$318k5.7%Plan not statedSEC
Jul 25, 2014LLYSr. VP & Pres., Lilly DiabetesForm 4 sale10,000$638k10.2%Plan not statedSEC
Aug 15, 2013LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$269k8.0%Plan not statedSEC
Jul 15, 2013LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$257k7.4%Plan not statedSEC
Jun 17, 2013LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$262k6.9%Plan not statedSEC
May 15, 2013LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$281k6.5%Plan not statedSEC
Apr 15, 2013LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$286k6.5%Plan not statedSEC
Aug 1, 2012LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$221k15.6%Plan not statedSEC
Jul 2, 2012LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$215k13.5%Plan not statedSEC
Jun 1, 2012LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$203k11.9%Plan not statedSEC
May 1, 2012LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$207k10.6%Plan not statedSEC
Apr 2, 2012LLYSr. VP & Pres., Lilly DiabetesForm 4 sale5,000$202k9.6%Plan not statedSEC